# Bleomycin Electrosclerotherapy (BEST) for Slow-flow Vascular Malformations

> **NCT07720570** · — · ENROLLING_BY_INVITATION · sponsor: **Copenhagen University Hospital, Rigshospitalet** · enrollment: 60 (estimated)

## Conditions studied

- Vascular Malformations

## Interventions

- **PROCEDURE:** Bleomycin electrosclerotherapy (BEST)

## Key facts

- **NCT ID:** NCT07720570
- **Lead sponsor:** Copenhagen University Hospital, Rigshospitalet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-08
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07720570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07720570, "Bleomycin Electrosclerotherapy (BEST) for Slow-flow Vascular Malformations". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07720570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*